A profitable company with growing sales. Institutions are adding.
Facts from SEC filings, not a recommendation.
Over 5 years, sales shrank about 9.1% a year.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, debt under half of equity, free cash flow positive. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions added 29.6% to their holdings. 76 bought, 42 sold.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
3,832 shares at $13.32 · $51K
17,242 shares at $13.47 avg ($13.32 to $13.61) · $232K
19,675 shares at $16.89 · $332K
1,613 shares at $15.68 · $25K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page